Merz Therapeutics: Staying focused while scaling a global neuroscience business
The global burden of neurological disease continues to create significant opportunities for pharmaceutical innovation. An estimated 1.2bn people worldwide were…
The global burden of neurological disease continues to create significant opportunities for pharmaceutical innovation. An estimated 1.2bn people worldwide were…
Artificial intelligence (AI) is unlikely to deliver a single breakthrough that makes cancer a disease of the past. Its more…
Following the US midterm elections, Arizona Senator Mark Kelly used day one of HLTH 2026 in Las Vegas to set…
Predictive maintenance, virtual process development, and artificial intelligence (AI)-assisted quality management are creating practical opportunities for pharmaceutical manufacturers. But the…
Osaka has the science. Now it needs to build the companies, capital and global reach to turn that science into…
Pharmaceutical Technology has introduced new ‘Premium Content’ for its readers – here’s an explanation of what’s changing and what isn’t.…
The opening of THE HIVE at Campus Grand Parc was marked not simply by the inauguration of a new laboratory…
Japan’s pharmaceutical industry - the world’s third largest by market value after the United States and China - has long…
Editor's note: This feature was reported in part prior to the escalation of hostilities in the Gulf, when Iran launched…
Nabta Health, a Dubai-based women's health company, is up for a prestigious MedTech award, but its founder Sophie Smith has…